ducovest

3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1258

Change

+2.50 (+0.20)%

Market Cap

N/A

Volume

180.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: HKD

Country : Hong Kong

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

 USD 1.17B
8355:HK I-CONTROL

N/A

 USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

N/A

 USD 0.31B
0648:HK CHINA RENJ

N/A

 USD 0.12B
0177-OL:HK JIANGSU EXPRESS

N/A

 N/A
0240-OL:HK BUILD KING HOLD

N/A

 N/A
0243-OL:HK QPL INT'L

N/A

 N/A
0182-OL:HK CHINA WINDPOWER

N/A

 N/A
0259-OL:HK YEEBO (INT'L H)

N/A

 N/A
0187-OL:HK JINGCHENG MAC

N/A

 N/A

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 7.69 % 0.43 %

N/A

 N/A
TETF 6.19 % 0.64 %

N/A

 N/A
IAI iShares U.S. Broker-Deale.. 4.70 % 0.42 %

N/A

 N/A
WBIF WBI BullBear Value 3000 E.. 4.37 % 1.05 %

N/A

 N/A
HDIV 2.83 % 0.00 %

N/A

 N/A
RYH 1.72 % 0.40 %

N/A

 N/A
DSTL Distillate US Fundamental.. 1.55 % 0.00 %

N/A

 USD 2.05B
FSWD:LSE iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

 N/A
IFSW:LSE iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

 N/A
IBCZ:F iShares IV Public Limited.. 1.47 % 0.00 %

N/A

 N/A
IS07:F iShares IV Public Limited.. 1.47 % 0.00 %

N/A

 N/A
HONR 1.20 % 0.65 %

N/A

 N/A
VVL:CA Vanguard Global Value Fac.. 0.66 % 0.40 %

N/A

 N/A
SMD 0.45 % 0.10 %

N/A

 N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

 USD 0.08B
JKH 0.00 % 0.30 %

N/A

 N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

 CAD 5.97M
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

N/A

 USD 0.09B
RYF 0.00 % 0.40 %

N/A

 N/A
XXM:CA 0.00 % 0.68 %

N/A

 N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

 N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.59% 75% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.59% 73% C 76% C+
Trailing 12 Months  
Capital Gain 26.48% 83% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.48% 81% B- 83% B
Trailing 5 Years  
Capital Gain 101.76% 86% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 101.76% 86% B+ 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 15.63% 80% B- 79% B-
Dividend Return 15.63% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.55% 73% C 73% C
Risk Adjusted Return 79.95% 98% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike